search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
INNOVATION


patients the opportunity to have a say about what innovations are important to them, which is a good outcome for patients. As the beneficiaries of new health technologies, patients have important experiences to share in developing routes to access innovations. “The recommendations are a step in the right direction in supporting the UK’s position as a leader in the life sciences, as we prepare to leave the European Union. We need to continue to work together to ensure the UK remains not only a great place to do research, but also enables patients fast and effective access in the NHS to the best technologies as they emerge.” Jeremy Farrar, Wellcome’s director,


said: “The UK can become the best place in the world to develop, test and roll out new healthcare innovations if we realise the full potential of the research base, industrial partnerships, patient capital and the NHS. “The review is a first step towards building the right environment and infrastructure within the NHS. It sets out an achievable strategy for getting the most promising drugs, devices, digital products and diagnostics to patients quickly, and transforming lives. Its success will depend on the close involvement of all stakeholders, and will need dedicated funding from the Government to support implementation.” To download the full report, visit: https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/ 565072/AAR_final.pdf


The UK can become the best place in the world to develop, test and roll out new healthcare innovations if we realise the full potential of the research base, industrial partnerships, patient capital and the NHS.


CSJ


Setting stand


td n


comes into it’ eprocessing an


r o sets the standard.


Miele leads the way in producing energy efficient machines with sparing use of water, electricity and chemicals. This helps to r both running costs andyp


your carbon footprint.


Complies with all the current DoH Guidelines including HTM 01-01 part D and EN15883.


Our fully qual provide both maintenance


ified technicians can user training and first line training for facilities staff.f


Through-flow heaters in direct contact with the water ensures efficiency with short cycle times.


Made in Germany helps to reduce


ng new dd


dards of clean


When quality and reliability are vital, Miele Professional s own. Our range of high quality instrument nd decontamination equipment for CSSD


o


0844 893 0760 miele.co.uk/pro/medicalro @MieleProf


MARCH 2017


WWW.CLINICALSERVICESJOURNAL.COM I


27


© motorlka - Fotolia


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72